Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 488 results for "ranbaxy lab"

Pharma shares on roll; CNX Pharma index hits new high
Business Standard

Pharma shares on roll; CNX Pharma index hits new high

Pharma, Ranbaxy Lab, Aurobindo, Glenmark Pharma, Strides Arcolab, Divi's Lab, Lupin and Cipla are up 1-6% on SI Reporter | Mumbai September 29, 2014 Last Updated at 11:00 IST Shares of pharmaceutical companies are on a roll with most of the frontline stocks ... Business Standard, 3 weeks ago
[x]  

1 images for "ranbaxy lab"

Sify, 1 week ago

Hold Ranbaxy Lab; target Rs 750-770: Akshata Deshmukh

Akshata Deshmukh, Chief Strategist-Trading at Networth Stock Broking is of the view that one may hold Ranbaxy Laboratories with a target of Rs 750-770.
 Money Control2 months ago Bull's Eye: Buy Lupin, HDFC; short HDIL, Reliance Capital  Money Control1 month ago Hold Ranbaxy Labs; target of Rs 615: KRChoksey  Money Control2 months ago Buy Ranbaxy Labs; target of Rs 605: Motilal Oswal  Money Control2 months ago

More exits from Ranbaxy Lab's top management team

With the fresh exits, nearly half of the members who were part of Ranbaxy’s executive committee two years ago will no longer be part of the team. NEW DELHI: Ranbaxy Laboratories' global HR head Sandeep Girotra has stepped down while its president of ...
 Economic Times2 months ago

Ranbaxy Lab gains on settling litigation concerning Texas Medicaid Program

Ranbaxy Laboratories is currently trading at Rs. 601.75, up by 3.70 points or 0.62% from its previous closing of Rs. 598.05 on the BSE. The scrip opened at Rs. 598.00 and has touched a high and low of Rs. 604.50 and Rs. 596.25 respectively. So far ...
 Arihant Capital1 week ago

Ranbaxy Lab receives Civil Investigative Demand from United States Department of Justice

The CID is a request for documents and information, and is not an allegation of wrongdoing or demand for compensation. Ranbaxy Laboratories Ltd has announced that the Company has received a Civil Investigative Demand ("CID") from the United States Department ...
 India Infoline1 month ago Ranbaxy Labs. - Receipt of Civil Investigative Demand ("CID"...  SBICAP Securities1 month ago Ranbaxy Labs. - Communication received from the Competition...  SBICAP Securities1 month ago

Ranbaxy Labs gains 1% on litigation settlement with Texas

Under the settlement agreement, Ranbaxy, which will soon become a subsidiary of Sun Pharma, will pay USD 39.75 million to State of Texas in a series of tranches through August 2015.
 Money Control1 week ago Ranbaxy Laboratories settles litigation; will pay USD 39.75mn to State of Texas  Moneycontrol.com1 week ago

Ranbaxy Laboratories: Updates on termination of GDR programme

Ranbaxy Laboratories Ltd has informed BSE that the Company has notified the Bank of New York Mellon (hereinafter R anbaxy Laboratories Ltd has informed BSE that the Company has notified the Bank of New York Mellon (hereinafter "The Bank") to ...
 Moneycontrol.com1 week ago Ranbaxy Laboratories' Q2 results on October 28, 2014  Moneycontrol.com3 weeks ago Ranbaxy Laboratories receives direction from CCI  Moneycontrol.com1 month ago

Dr Reddy's, MM, Maruti to get astro support: Gupta

According to Satish Gupta of astrostocktips, pharma stocks like Dr Reddy's Labs, Ranbaxy Labs, Sun Pharma and Glenmark Pharma will get astro support.
 Money Control1 week ago Cipla, TCS, Ranbaxy, Polaris to get astro support: Gupta  Money Control1 month ago

Stocks in news: Reliance Ind, DLF, Bajaj Auto, ILFS Engg

Reliance Industries | DLF | Bajaj Auto | Liberty Shoes | ILFS Engineering | Tata Power | Ranbaxy Labs | UCO Bank | UPL | Novartis India and Tata Steel are stocks, which are in the news today.
 Money Control1 week ago
India TV

CCI: Sun-Ranbaxy deal may hurt competition

12:06 am New Delhi : Launching the first-ever public scrutiny of an M&A deal in India, fair trade watchdog CCI said it has prima facie found that the $4-billion merger of Ranbaxy Labs into rival Sun Pharma is likely to have an appreciable adverse ...
 The Freepress Journal1 month ago Sun-Ranbaxy deal may hit fair trade: CCI  Times of India1 month ago Sun-Ranbaxy deal may hit competition: CCI  VC Circle1 month ago CCI begins Sun-Ranbaxy deal's public scrutiny; seeks notes  Moneycontrol.com1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less